Home > Insider Trading > Filing (0001209191-16-107451)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365369	F John Sheridan	C/O Tandem Diabetes Care, Inc., 11045 Roselle Street San Diego CA 92121	Evp, Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-01-04	2,000	$1.11	7,295	No	4	M	Direct
Common Stock	Disposition	2016-01-04	2,000	$11.47	5,295	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2016-01-04	2,000	$0.00	2,000	$1.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
110,040	2013-02-25	2023-04-23	No	4	M	Direct

Footnotes

Includes 1,211 shares acquired under the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP") on November 13, 2015.
This amendment is being filed to correct the amount of securities beneficially owned.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2015, at a price of $11.4721. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The option became 25% exercisable on 2/25/2014 and in 36 equal monthly installments thereafter.